Defining ‘Good Clinical Practice’

  • Sarah G. Mars
Chapter
Part of the Science, Technology and Medicine in Modern History book series (STMMH)

Abstract

Hostilities between private prescribers and their critics did not cease with Treatment and Rehabilitation. Attacks from each side continued in medical journals2 and carried over into a new arena of medical regulation: guidelines on good clinical practice. Published in 1984 by the Department of Health and Social Security (DHSS),3 these first official guidelines in British medicine were followed thick and fast by many more, particularly after the NHS market reforms of 1991. Some have represented this as an increase in state control over the medical profession and a weakening of doctors’ autonomy.4 However, this chapter argues that these guidelines embodied the use of regulation by an alliance of one part of the medical profession with an arm of the state to control the practice of a second group of doctors.

Keywords

Good Clinical Practice Treat Drug User Methadone Maintenance Treatment General Medical Council Consultant Psychiatrist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

  1. 2.
    For example, Dally, A. ‘Drug clinics today’ [letter], The Lancet, 8328 (1983), 826.CrossRefGoogle Scholar
  2. 4.
    S. Harrison and W. I. U. Ahmad, ‘Medical autonomy and the UK state 1975–2025’, Sociology, 34 (2000), 129–146.CrossRefGoogle Scholar
  3. 5.
    A. Thorley, ‘Longitudinal studies of drug dependence’ in G. Edwards and C. Busch (eds.) Drug Problems in Britain: A Review of Ten Years (London: Academic Press, 1981), pp. 117–169.Google Scholar
  4. 6.
    M. Mitcheson, ‘Drug clinics in the 1970s’ in J. Strang and M. Gossop (eds.), Heroin Addiction and Drug Policy: The British System (Oxford, New York and Tokyo: Oxford University Press, 1994), pp. 179–191.Google Scholar
  5. 7.
    R. Hartnoll, M. C. Mitcheson, A. Battersby, G Brown, M Ellis, P. Fleming, and N. Hedley, ‘Evaluation of heroin maintenance in controlled trial’, Archives of General Psychiatry, 37 (1980), 877–884.CrossRefGoogle Scholar
  6. 10.
    G. V. Stimson and E. Oppenheimer, Heroin Addiction: Treatment and Control in Britain (London: Tavistock Publications, 1982), pp. 215–219.Google Scholar
  7. 13.
    H. B. Spear (and ed. J. Mott), Heroin Addiction Care and Control: the ‘British System’ 1916–1984 (London: Drugscope, 2002), pp. 245–246.Google Scholar
  8. 14.
    J. Strang, ‘“The British System”: past, present and future’, International Review of Psychiatry, 1 (1989), p. 113.CrossRefGoogle Scholar
  9. 15.
    DHSS, ‘Drug dependence: clinical conference’ [Minutes of meeting] (28th November 1968), Private archive.Google Scholar
  10. 19.
    J. H. Willis, ‘Unacceptable face of private practice: prescription of controlled drugs to addicts’ [letter], British Medical Journal, 287 (1983), 500.CrossRefGoogle Scholar
  11. 20.
    Department of Health and Social Security, Department of Education and Science, Home Office and Manpower Services Commission, Misuse of Drugs with Special Reference to the Treatment and Rehabilitation of Misusers of Hard Drugs: Government Response to the Fourth Report from the Social Services Committee Session 1984–85 (London: HMSO, 1985), pp. 18–19.Google Scholar
  12. 22.
    See ACMD, Treatment and Rehabilitation, DHSS (London: HMSO, 1982), pp. 26–27.Google Scholar
  13. 23.
    J. Strang, ‘Personal view’, British Medical Journal, 283 (1981), 376.CrossRefGoogle Scholar
  14. 24.
    AIDA, ‘Drug Addiction: Guidelines and Standards in Management’, Pre-publication edition, February 1982, File PP/DAL/B/4/1/1/5, Wellcome Library.Google Scholar
  15. 25.
    AIDA, ‘Minutes of first meeting of the Working Party’ (24th November, 1981), File PP/DAL/B/4/1/1/4, Wellcome Library, London.Google Scholar
  16. 26.
    W. Laing, Going Private. Independent Health Care in London (London: King’s Fund, 1992).Google Scholar
  17. 27.
    C. Webster, The National Health Service. A Political History (Oxford: Oxford University Press, 1998), p. 146.Google Scholar
  18. 33.
    V. Berridge, ‘Doctors and the state: the changing role of medical expertise in policy-making’, Contemporary British History, 11 (1997), 66–85.CrossRefGoogle Scholar
  19. 41.
    For example, T. Waller and A. Banks, ‘Drug abuse pull out supplement’, GP (25th March 1983), 27–45Google Scholar
  20. and A. Banks and T. A. N. Waller, Drug Addiction and Polydrug Use: The Role of the General Practitioner (London: ISDD, 1983).Google Scholar
  21. 42.
    For example, E. Tylden, ‘Care of the pregnant drug addict’, MIMS, 1st June (1983), 1–4.Google Scholar
  22. 48.
    T. Bewley, ‘Drug dependence in the USA’, Bulletin on Narcotics, XXI, 2 (1969), 13–29.Google Scholar
  23. 54.
    A. Dally, A Doctor’s Story (London: Macmillan, 1990), pp. 127–132.Google Scholar
  24. 56.
    H. D. Beckett, ‘Heroin, the gentle drug’, New Society, 49, 877 (1979), 181–182.Google Scholar
  25. 74.
    ACMD, Treatment and Rehabilitation, DHSS (London: HMSO, 1982), p. 59.Google Scholar
  26. 79.
    UK Health Departments, Drug Misuse and Dependence. Guidelines on Clinical Management (London: The Stationery Office, 1999), p. 47Google Scholar
  27. 80.
    For example, DHSS, Better Services for the Mentally Ill (London: HMSO, 1975) pp. 68–70 and ACMD (1982), pp. 81–86.Google Scholar
  28. 81.
    J. L. Reed, ‘Meeting of Doctors Working in London Drug Dependency Treatment Centres, November 25th, 1969 at St Bartholomew’s Hospital’ [Minutes], Private Archive.Google Scholar
  29. 84.
    D. Black, ‘Medical Working Group on Drug Dependence’ (1985), File 16/DAC 28/2, DH Archive, Nelson, Lancashire.Google Scholar
  30. 89.
    For the prescribing figures and a more detailed discussion, see S. G. Mars, Prescribing and Proscribing: The Public-Private Relationship in the Treatment of Drug Addiction in England, 1970–99 (University of London: PhD Thesis, 2005), pp. 103–104.Google Scholar
  31. 90.
    D. Acheson, Memo to Ms Bateman (30th October 1985), File 16/DAC 28/2, DH Archive, Nelson, Lancashire.Google Scholar
  32. 91.
    D. Black, ‘Medical Working Group on Drug Dependence Report on the Feasibility of the Extension of Licensing Restrictions to All Opioid Drugs’ Memo to Dr Mason, Dr Oliver and Ms McKessack. (1st October 1985), File 16/DAC 28/2, DH Archive, Nelson, Lancashire.Google Scholar
  33. 94.
    For example, K. Clarke, ‘Tackling drugs misuse’ (31st October 1983), File DAC 14/4, DH Archive, Nelson, Lancashire.Google Scholar
  34. 101.
    A. Dally, A Doctor’s Story (London: Macmillan, 1990), pp. 127–132.Google Scholar
  35. 110.
    Department of Health (England) and the devolved administrations, Drug Misuse and Dependence: UK Guidelines on Clinical Management (London: Department of Health [England], the Scottish Government, Welsh Assembly Government and Northern Ireland Executive, 2007).Google Scholar
  36. 112.
    R. Hartnoll, M.C. Mitcheson, A. Battersby, et al., ‘Evaluation of heroin maintenance in controlled trial’, Archives of General Psychiatry, 37 (1980), 877–884.CrossRefGoogle Scholar
  37. 113.
    J. Strang, ‘“The British System”: past, present and future’, International Review of Psychiatry, 1 (1989), 109–120, p. 116.CrossRefGoogle Scholar
  38. 115.
    S. M. Shortell, ‘Occupational prestige differences within the medical and allied health professions’, Social Science and Medicine, 8 (1974), 1–9.CrossRefGoogle Scholar
  39. 121.
    T. H. Bewley and R. S. Fleminger, ‘Staff/patient problems in drug dependence treatment clinics’, Journal of Psychosomatic Research, 14 (1970), 303–306, p. 306.CrossRefGoogle Scholar
  40. 123.
    J.H. Willis, ‘Unacceptable face of private practice: prescription of controlled drugs to addicts’ [letter], British Medical Journal, 287 (1983), 500.CrossRefGoogle Scholar
  41. 127.
    V. Berridge, ‘AIDS and the rise of the patient? Activist organisation and HIV/AIDS in the UK in the 1980s and 1990s’, Medizin Gesellschaft und Geschichte, 21 (2002), 109–123.Google Scholar
  42. 130.
    A. Burr, ‘The Piccadilly drug scene’, British Journal of Addiction, 78, 1 (1983), 5–19.CrossRefGoogle Scholar
  43. 132.
    R. Klein, The New Politics of the National Health Service (London and New York: Longman, first published 1983, third edition 1995), pp. 243–244.Google Scholar
  44. 135.
    J. Stanton, ‘What shapes vaccine policy? The case of hepatitis B in the UK’, Social History of Medicine, 7, 3 (1994), 427–446.CrossRefGoogle Scholar

Copyright information

© Sarah G. Mars 2012

Authors and Affiliations

  • Sarah G. Mars
    • 1
    • 2
  1. 1.Heroin Price and Purity Outcomes StudyUniversity of San FranciscoUSA
  2. 2.London School of Hygiene and Tropical MedicineUK

Personalised recommendations